: Atai says its depression treatment failed in a mid-stage clinical trial
Shares of Atai Life Sciences NV ATAI tumbled about 44% in premarket trading on Friday after the company said a Phase 2a clinical trial evaluating...
: Silvergate Capital stock falls another 8.5%; JPMorgan downgrades company to neutral
Silvergate Capital Corp. SI stock shed an additional 8.5% in premarket trades on Friday, on top of a nearly 43% loss on Thursday after a...
: Comcast elevates Jason Armstrong to CFO
Comcast Corp. CMCSA has elevated Jason Armstrong to the role of chief financial officer, the cable and media giant announced Friday. Armstrong, who has served...
Traders raise chances of quarter-of-a-percentage-point Fed rate hikes in February and March after December jobs report
Fed funds futures traders see a better-than-not likelihood that the Federal Reserve will lift rates by a smaller-than-usual 25 basis points each at its next...
U.S. stocks open higher after employment report shows wage growth cooling
U.S. stocks opened higher at the opening bell as investor digested an employment report that showed signs of wage growth slowing in a strong labor...
BioNTech says it will start cancer vaccine trials in the UK from September
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
Automakers are cautiously optimistic for a 2023 rebound after worst new vehicle sales in more than a decade
Automakers are hoping last year's new vehicle sales — the worst in more than a decade will mark a bottom for the market.
Need to Know: Citi has just cut its rating on U.S. stocks to underweight. Here’s why and what it prefers.
Citi's global strategy team looked around the world and decided to cut its recommendation on the U.S. to underweight from overweight.
: Southwest sees flight cancellations costing up to $825 million
Southwest Airlines warned of a surprise fourth-quarter net loss, due to costs resulting from the more than 16,700 flights canceled late-December